Tectonic Advisors LLC Sells 60 Shares of CME Group Inc. $CME

Tectonic Advisors LLC reduced its position in CME Group Inc. (NASDAQ:CME) by 4.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,263 shares of the financial services provider’s stock after selling 60 shares during the period. Tectonic Advisors LLC’s holdings in CME Group were worth $348,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of CME. GQG Partners LLC lifted its holdings in shares of CME Group by 7,676.3% in the 1st quarter. GQG Partners LLC now owns 2,205,041 shares of the financial services provider’s stock worth $584,975,000 after purchasing an additional 2,176,685 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of CME Group by 370.5% in the 1st quarter. Wellington Management Group LLP now owns 2,653,957 shares of the financial services provider’s stock worth $704,068,000 after purchasing an additional 2,089,935 shares in the last quarter. Nuveen LLC bought a new position in shares of CME Group in the 1st quarter worth $218,842,000. Alliancebernstein L.P. lifted its holdings in shares of CME Group by 185.5% in the 1st quarter. Alliancebernstein L.P. now owns 1,244,608 shares of the financial services provider’s stock worth $330,182,000 after purchasing an additional 808,740 shares in the last quarter. Finally, Egerton Capital UK LLP lifted its holdings in shares of CME Group by 79.4% in the 1st quarter. Egerton Capital UK LLP now owns 1,730,194 shares of the financial services provider’s stock worth $459,003,000 after purchasing an additional 765,773 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other CME Group news, Director William R. Shepard bought 262 shares of the firm’s stock in a transaction dated Thursday, September 25th. The stock was purchased at an average cost of $265.19 per share, with a total value of $69,479.78. Following the transaction, the director directly owned 258,459 shares in the company, valued at $68,540,742.21. This trade represents a 0.10% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the sale, the insider directly owned 17,440 shares of the company’s stock, valued at approximately $4,734,436.80. This trade represents a 40.55% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Oppenheimer increased their target price on CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a report on Thursday, July 24th. Wall Street Zen lowered CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. JPMorgan Chase & Co. increased their price target on CME Group from $246.00 to $252.00 and gave the company an “underweight” rating in a research report on Thursday, September 25th. Morgan Stanley increased their price target on CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a research report on Wednesday, October 1st. Finally, Jefferies Financial Group lowered their price target on CME Group from $313.00 to $304.00 and set a “buy” rating for the company in a research report on Friday. Seven analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, CME Group currently has an average rating of “Hold” and a consensus price target of $281.00.

CME Group Trading Up 1.0%

Shares of CME Group stock opened at $271.45 on Friday. CME Group Inc. has a 1 year low of $213.94 and a 1 year high of $290.79. The firm has a market cap of $97.83 billion, a PE ratio of 26.28, a P/E/G ratio of 5.67 and a beta of 0.41. The stock has a fifty day moving average price of $268.89 and a 200-day moving average price of $271.17. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The firm had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period last year, the firm posted $2.56 EPS. The business’s revenue was up 10.4% compared to the same quarter last year. Equities research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Stockholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. CME Group’s dividend payout ratio (DPR) is currently 48.40%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.